Lexicon Pharmaceuticals
LXRX
#6646
Rank
ยฃ0.62 B
Marketcap
ยฃ1.41
Share price
0.54%
Change (1 day)
18.92%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -ยฃ45.8 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ41.46 Million. In 2025 the company made an earning of -ยฃ37.98 Million, an increase over its 2024 earnings that were of -ยฃ0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ45.8 Million20.61%
2025 -ยฃ37.98 Million-74.88%
2024 -ยฃ0.16 Billion13.15%
2023 -ยฃ0.14 Billion73.74%
2022 -ยฃ76.9 Million16.16%
2021 -ยฃ66.2 Million49.82%
2020 -ยฃ44.19 Million-147.19%
2019 ยฃ93.62 M-203.42%
2018 -ยฃ90.53 Million-15.31%
2017 -ยฃ0.11 Billion0.2%
2016 -ยฃ0.11 Billion2920.7%
2015 -ยฃ3.54 Million-95.33%
2014 -ยฃ75.71 Million-3.61%
2013 -ยฃ78.55 Million-5.52%
2012 -ยฃ83.13 Million-4.17%
2011 -ยฃ86.75 Million15.5%
2010 -ยฃ75.11 Million8.36%
2009 -ยฃ69.32 Million-4.81%
2008 -ยฃ72.82 Million28.79%
2007 -ยฃ56.54 Million35.71%
2006 -ยฃ41.66 Million52.91%
2005 -ยฃ27.25 Million-23.89%
2004 -ยฃ35.8 Million-24.19%
2003 -ยฃ47.22 Million-0.48%
2002 -ยฃ47.44 Million44.12%
2001 -ยฃ32.92 Million23.01%
2000 -ยฃ26.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ5.95 B-13,024.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ0.84 B-1,927.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ4.28 B-9,404.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ0.34 Billion 631.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ45.94 M-199.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ59.88 M-229.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ17.54 Million-61.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ32.93 M-171.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ12.47 Million-72.97%๐Ÿ‡บ๐Ÿ‡ธ USA